These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 5701557)

  • 101. Role of acidosis in renal osteomalacia.
    Cochran M; Nordin BE
    Br Med J; 1969 May; 2(5652):276-9. PubMed ID: 5780454
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Pharmacological suppression of hyperparathyroidism in patients treated by periodical hemodialysis. Histological, hormonal, biochemical and radiological study].
    Brancaccio D; Faccini JM; Graziani G; Banfi G; Pedoja G; Watson L
    Minerva Nefrol; 1976; 23(2):149-53. PubMed ID: 1087389
    [No Abstract]   [Full Text] [Related]  

  • 103. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM; Skillen AW; Ellis HA
    J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
    [TBL] [Abstract][Full Text] [Related]  

  • 105. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
    Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
    Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
    [No Abstract]   [Full Text] [Related]  

  • 106. [Radiologic changes in the pelvis of patients with chronic renal insufficiency undergoing periodic dialysis].
    Marini M; Guerrisi R; Vidiri A; Ponzio R
    Radiol Med; 1990 Sep; 80(3):263-71. PubMed ID: 2236684
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
    Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
    Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
    [TBL] [Abstract][Full Text] [Related]  

  • 108. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D; Galmozzi C; Pizzocaro G
    Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract]   [Full Text] [Related]  

  • 109. Azotemic renal osteodystrophy.
    WEBSTER GD
    Med Clin North Am; 1963 Jul; 47():985-1000. PubMed ID: 13999407
    [No Abstract]   [Full Text] [Related]  

  • 110. Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis.
    El Shahat Y; Jacobs C; Issad B; Rottembourg J; Legrain M
    Adv Exp Med Biol; 1982; 151():429-40. PubMed ID: 7180661
    [No Abstract]   [Full Text] [Related]  

  • 111. [Renal osteodystrophy: bone disease with renal disease].
    Shigematsu T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():435-42. PubMed ID: 11979940
    [No Abstract]   [Full Text] [Related]  

  • 112. Bone disease in moderate renal failure: cause, nature and prevention.
    Bushinsky DA
    Annu Rev Med; 1997; 48():167-76. PubMed ID: 9046953
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Management of bone disease in the dialysis patient.
    Crooks PW; Coburn JW
    Blood Purif; 1985; 3(1-3):27-41. PubMed ID: 3913448
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Renal osteodystrophy].
    Montandon A
    Ther Umsch; 1969 Nov; 26(11):633-9. PubMed ID: 4903130
    [No Abstract]   [Full Text] [Related]  

  • 115. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG; Nielsen LP; Mogensen NB
    Nephron; 1983; 35(2):103-7. PubMed ID: 6621754
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Focus on vitamin D therapy in chronic kidney disease.
    Tentori F
    J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134
    [No Abstract]   [Full Text] [Related]  

  • 117. [Chronic renal insufficiency in children treated for several months with hemodialysis and peritoneal dialysis. Comparative study].
    Dumas R; Chable JP; Bonnet H; Jean R
    Arch Fr Pediatr; 1971; 28(7):741-55. PubMed ID: 5125215
    [No Abstract]   [Full Text] [Related]  

  • 118. Hypercalcemia after renal transplantation.
    Schwartz GH; David DS; Riggio RR; Saville PD; Whitsell JC; Stenzel KH; Rubin AL
    Am J Med; 1970 Jul; 49(1):42-51. PubMed ID: 4914475
    [No Abstract]   [Full Text] [Related]  

  • 119. Role of aluminum in uremic osteodystrophy.
    Luciani L; Rovelli E; Colleoni N; Mocetti P; Ballanti P; Bonucci E; D'Amico G
    Contrib Nephrol; 1990; 77():168-76. PubMed ID: 2188785
    [No Abstract]   [Full Text] [Related]  

  • 120. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.
    Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G
    Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.